May 28, 2017 5:50 AM ET

Biotechnology

Company Overview of Octagen Corporation

Company Overview

Octagen Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of hemophilia and genetic disorders of the clotting process. It develops two variations of recombinant B domain deleted porcine factor VIII to avoid inactivation by flying below the radar screen of the immune system. The company was founded in 1997 and is based in Narberth, Pennsylvania. As of July 17, 2008, Octagen Corporation operates as a subsidiary of Ipsen S.A.

717 Braeburn Lane

Narberth, PA 19072

United States

Founded in 1997

Phone:

610-664-2222

Key Executives for Octagen Corporation

Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Octagen Corporation, please visit www.octagen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.